Clicky

Standard BioTools Inc.(LAB)

Description: Standard BioTools, previously known as Fluidigm, is driven by a bold vision – unleashing tools to accelerate breakthroughs in human health. Standard BioTools has an established portfolio of essential, standardized next-generation technologies that help biomedical researchers develop medicines faster and better. As a leading solutions provider, the Company provides reliable and repeatable insights in health and disease using its proprietary mass cytometry and microfluidics technologies that help transform scientific discoveries into better patient outcomes. Standard BioTools works with leading academic, government, pharmaceutical, biotechnology, plant and animal research, and clinical laboratories worldwide, focusing on the most pressing needs in translational and clinical research, including oncology, immunology, and immunotherapy.


Keywords: Natural Sciences Biotechnology Disease Immunotherapy Medical Research Flow Cytometry

Home Page: www.fluidigm.com

LAB Technical Analysis

2 Tower Place
South San Francisco, CA 94080
United States
Phone: 650 266 6000


Officers

Name Title
Mr. Vikram Jog Chief Financial Officer
Dr. Michael Egholm Ph.D. Pres, CEO & Director
Dr. Stephen R. Quake D.phil., Ph.D. Co-Founder & Chairman of Advisory Board
Mr. Hanjoon Kim Chief Operating Officer
Mr. Andrew Quong Ph.D. Chief Science Officer
Mr. Peter DeNardo Investor Relations
Mr. Rafael Aguirre-Sacasa Acting Gen. Counsel
Mark Spearman Sr. Director of Corp. Communications
Ms. Angela Peters Chief HR Officer
Dr. David A. King Ph.D. Sr. VP of Global R&D

Exchange: NASDAQ

Country: US

Currency: US Dollar ($)

Forward PE: 0
Trailing PE: 0
Price-to-Book MRQ: 5.8691
Price-to-Sales TTM: 0.9876
IPO Date: 2003-07-29
Fiscal Year End: December
Full Time Employees: 615
Back to stocks